Ana Barreira-Diaz

8PUBLICATIONS
52CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)HaematologyCellular immunologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 29, 2026
Revisiting Ferritin-IgG Score to Predict Complete Biochemical Response in Autoimmune Hepatitis.

|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Rui Huang, Ai-Thien Do, Hidenori Toyoda

|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.

Mar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban

|Feb 08, 2024
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.

Mar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo

|Dec 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study.

Anna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando

|Jan 10, 2023
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Álvaro Díaz-González, Manuel Hernández-Guerra, Indhira Pérez-Medrano

Pageof 2

Frequent Collaborators

5 joint publications

Mar Riveiro-Barciela

3 joint publications

Beatriz Mateos

3 joint publications

María-Carlota Londoño

3 joint publications

Juan-Carlos Ruiz-Cobo